Pilot Study: PARP1 Imaging in Advanced Prostate Cancer

ConclusionsFTT-PET/CT may serve as an alternate biomarker for PARP1 expression and a potential method for PARPi treatment selection.
Source: Molecular Imaging and Biology - Category: Molecular Biology Source Type: research